Dexamethasone Treatment for COVID-19 is Related with Increased Mortality in Haematological Malignancy Patients: Results from the EPICOVIDEHA Registry.
Alternative Title
Abstract
n/a
Description
Citation
Aiello, T.F., Salmanton-Garcia, J., Marchesi, F. et al. (2024) Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica; Advance online publication.
Publisher
Haematologica
License
Journal
Volume
Issue
PubMed ID
ISSN
1592-8721